Securities code: Hunan Warrant Pharmaceutical Co.Ltd(688799) securities abbreviation: Hunan Warrant Pharmaceutical Co.Ltd(688799) Announcement No.: 2022009 Hunan Warrant Pharmaceutical Co.Ltd(688799)
Announcement on the remuneration scheme of directors, supervisors and senior managers in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Hunan Warrant Pharmaceutical Co.Ltd(688799) (hereinafter referred to as “the company”) formulates the remuneration plan for directors, supervisors and senior managers in 2022 in accordance with the Hunan Warrant Pharmaceutical Co.Ltd(688799) articles of association, Hunan Warrant Pharmaceutical Co.Ltd(688799) director, supervisor and senior management remuneration management system and other relevant systems, in combination with the actual operation of the company and with reference to the remuneration level of the industry and region. The remuneration scheme of directors and supervisors needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. The specific contents are hereby announced as follows: I. applicable objects
Directors (including independent directors), supervisors and senior managers in the company
2、 Applicable time
January 1, 2022 to December 31, 2022
3、 Salary standard
(I) directors’ remuneration
1. Independent Directors receive remuneration from the company in the form of fixed allowance, and the allowance standard is 80000 yuan / year (before tax); All expenses arising from the performance of duties shall be borne by the company.
2. Directors serving in the company shall receive remuneration according to their operation and management positions in the company, and shall no longer receive director’s allowance.
3. Other non independent directors who do not hold office in the company receive fixed allowances according to the standard of independent directors, and all expenses incurred for performing their duties shall be borne by the company.
(II) remuneration of supervisors
1. Supervisors who do not work in the company receive fixed allowance according to the standard of independent directors, and the allowance standard is 80000 yuan / year (before tax); All expenses arising from the performance of duties shall be borne by the company.
2. Supervisors serving in the company will receive remuneration according to their positions in the company and will no longer receive supervisor allowance. (III) remuneration of senior managers
According to the specific positions of senior managers in the company and after assessment according to the company’s salary management system, they will receive salary.
4、 Other provisions
If the directors, supervisors and senior managers of the company leave their posts due to change of office, re-election, resignation and dismissal during their term of office, they shall be calculated and paid according to their actual term of office.
It is hereby announced.
Hunan Warrant Pharmaceutical Co.Ltd(688799) board of directors March 29, 2022
